Patent details

EP3085385 Title: PHARMACEUTICAL COMPOSITION COMPRISING ADALIMUMAB

Basic Information

Publication number:
EP3085385
PCT Application Number:
CN2014093722
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148715360
PCT Publication Number:
WO2015090162
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITION COMPRISING ADALIMUMAB
French Title of Invention:
COMPOSITION PHARMACEUTIQUE CONTENANT DE L'ADALIMUMAB
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT ADALIMUMAB
SPC Number:

Dates

Filing date:
12/12/2014
Grant date:
25/08/2021
EP Publication Date:
26/10/2016
PCT Publication Date:
25/06/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/08/2021
EP B1 Publication Date:
25/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/12/2021
Expiration date:
12/12/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/08/2021
 
 

Name:
Hisun Biopharmaceutical Co., Ltd.
Address:
8 of Haizheng Road, Xukou Town Fuyang District, Hangzhou City, Zhejiang Province, China (CN)

Inventor

1

Name:
QIU, Minhong
Address:
China (CN)

2

Name:
FANG, Weijie
Address:
China (CN)

3

Name:
WANG, Haibin
Address:
China (CN)

4

Name:
BAI, Hua
Address:
China (CN)

5

Name:
ZHENG, Hongjian
Address:
China (CN)

6

Name:
YING, Yuebin
Address:
China (CN)

Priority

Priority Number:
201310693338
Priority Date:
16/12/2013
Priority Country:
China (CN)

Classification

IPC classification:
A61K 39/395; C07K 16/24; A61P 37/00;

Publication

European Patent Bulletin

Issue number:
202134
Publication date:
25/08/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages